The FDA granted standard approval to pembrolizumab (Keytruda) plus trastuzumab (Herceptin) and chemotherapy for the treatment of patients with HER2-positive locally advanced unresectable or metastatic ...

Colossal Biosciences is interested in resurrecting New Zealand’s extinct species like the moa and Haast's eagle. Photo / John Megahan, PLOS Biology A paleogeneticist has warned that discussions ...

"Nagsabi na sila, kagabi pa," said Commissioner Willie Marcial on the shattered wall in the TNT dugout, adding they are only waiting for a bill by MOA management which they will then turn over to ...

The study by Ma et al. provides fundamental findings and compelling evidence that Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A ...

This study provides valuable insights into the efficacy and safety of pyrotinib as an extended adjuvant therapy following trastuzumab-based treatment in patients with high-risk HER2-positive breast ...

The antibody-drug conjugate trastuzumab deruxtecan has been approved since January 2021 for pretreated adults with HER2-positive breast cancer that has metastasized or can no longer be operated on.